Brief: Valbiotis Announces Totum 63 Clinical Study Success

Valbiotis SA

07/11/2023 16:43

Nov 7 (Reuters) - Valbiotis SA  ALVAL.PA :
    * VALBIOTIS ANNOUNCES THE SUCCESS OF THE TOTUM 63  MODE OF
ACTION
CLINICAL STUDY, AGAINST PREDIABETES  AND THE EARLY STAGES OF
TYPE 2 DIABETES
    * STUDY CONFIRMS TOTUM 63'S EFFICACY RESULTS, IN PARTICULAR
LASTING REDUCTION IN GLYCATED HEMOGLOBIN, ONE OF MAIN MARKERS OF
PREDIABETES AND TYPE 2 DIABETES

Source text for Eikon:  ID:nEQ1Npzwna 
Further company coverage:  ALVAL.PA 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))